Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
Malay Mail on MSN17h
Singapore biotech tycoon Huang Zhenhua’s assets frozen over US$830m suit after misleading Novo Nordisk on ‘new and effective’ hypertension drug, court rulesDanish pharmaceutical giant Novo Nordisk has secured a court order to freeze the worldwide assets of Singapore-based KBP Biosciences and its founder Huang Zhenhua, amid a legal battle over an ...
The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback